VB-111 Clinical Data Presented at ASCO Demonstrate Significant Increase in Overall

... Read more

Read more

Verastem Announces Presentation of Scientific Data Supporting FAK Inhibition in

... Read more

Verastem Announces Positive Top-line Data from the Pivotal Phase 3 DUO ™

... Read more

Environmental License Granted: Verde AgriTech en route to

... Read more

Vericel Announces Positive Top-Line Results From Phase 2b ixCELL-DCM Clinical

... Read more

Vertex Energy, Inc.

... Read more

Two 24-Week Phase 3 Studies of Lumacaftor in Combination with Ivacaftor Met Primary Endpoint with Statistically Significant Improvements

... Read more

VirnetX Announces Denial of All RPX's Petitions for Patent Review

... Read more

VirnetX Announces Denial of

... Read more